FORTE BIOSCIENCES INC (FBRX) Stock Balance Sheet
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 45.86M | 22.24M | 37.13M | 41.10M | 42.00M | |||
| Marketable Securities | 0.00 | 36.12M | N/A | N/A | N/A | |||
| Other Current Assets | 1.30M | 2.98M | 1.20M | 400.00K | 500.00K | |||
| Total Current Assets | 47.16M | 61.35M | 38.33M | 41.50M | 42.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 125.00K | 77.00K | 109.00K | N/A | 0.00 | |||
| Investments And Advances | 112.00K | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 39.00K | 87.00K | 491.00K | 500.00K | 800.00K | |||
| Total Non-Current Assets | 301.00K | 215.00K | 653.00K | 500.00K | 800.00K | |||
| TOTAL ASSETS | 47.46M | 61.56M | 38.98M | 42.00M | 43.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.01M | 4.20M | 2.24M | 2.00M | 800.00K | |||
| Accounts Payable | 5.02M | 4.88M | 1.42M | 1.20M | 900.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 9.03M | 9.08M | 3.67M | 3.20M | 1.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 9.03M | 9.08M | 3.67M | 3.20M | 1.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -169.65M | -154.00M | -118.52M | -87.00M | -73.20M | |||
| Additional Paid In Capital | 208.07M | 206.46M | 153.79M | 125.80M | 114.70M | |||
| Common Shares | 6.00K | 6.00K | 36.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 11.00K | 4.00K | N/A | N/A | |||
| Shares Outstanding | 6.58M | 6.39M | 1.45M | 21.00M | 14.80M | |||
| Tangible Book Value per Share | 5.84 | 8.21 | 24.30 | 1.85 | 2.80 | |||
| Total Shareholders' Equity | 38.43M | 52.48M | 35.31M | 38.80M | 41.50M | |||
| TOTAL LIABILITIES AND EQUITY | 47.46M | 61.56M | 38.98M | 42.00M | 43.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.22 | 6.76 | 10.45 | 12.97 | 23.61 | |||
| Return On Assets (ROA) | -93.14% | -56.85% | -79.53% | -33.05% | -50.14% | |||
| Return On Equity (ROE) | -115.03% | -66.69% | -87.78% | -35.77% | -52.31% | |||
All data in USD , ROIC based on taxRate of 0.21